Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (71-80 of 858) with videos related to

Pageof 86
Sort By:
Critical Pathways in Cardiology|November 28, 2022
20 Years of Critical PathwaysChristopher P Cannon, Liuba Fusco
Journal of Interventional Cardiology|November 29, 2007
Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary interventionAmit Kumar, Christopher P Cannon
Reviews in Cardiovascular Medicine|October 28, 2008
Acute coronary syndrome. Cardiovascular events after clopidogrel discontinuationChristopher P Cannon, Subroto Acharjee
Critical Pathways in Cardiology|August 31, 2010
Office-based global cardiometabolic risk assessment: a simple tool incorporating nontraditional markersSubroto Acharjee, Christopher P Cannon
Critical Pathways in Cardiology|December 2, 2010
Duration of dual antiplatelet therapy following percutaneous coronary intervention with drug-eluting stents: a review of recent evidenceSubroto Acharjee, Christopher P Cannon
Arteriosclerosis, Thrombosis, and Vascular Biology|October 22, 2010
Could direct inhibition of inflammation be the "next big thing" in treating atherosclerosis?Pradeep Natarajan, Christopher P Cannon
Nature Reviews. Cardiology|December 21, 2011
Acute coronary syndromes in 2011: Walking the tightrope between efficacy and bleedingPayal Kohli, Christopher P Cannon
Clinical Cardiology|November 30, 2012
The importance of matching language to type of evidence: avoiding the pitfalls of reporting outcomes dataPayal Kohli, Christopher P Cannon
Heart Failure Clinics|April 25, 2008
The role of statins in the prevention of heart failure after acute coronary syndromeAmit Kumar, Christopher P Cannon
Clinical Cardiology|June 29, 2012
Aspirin resistance: current status and role of tailored therapyJonathan Grinstein, Christopher P Cannon
Pageof 86

Showing results (71-80 of 858) with videos related to

Sort By:
Pageof 86
Critical Pathways in Cardiology|November 28, 2022
20 Years of Critical PathwaysChristopher P Cannon, Liuba Fusco
Journal of Interventional Cardiology|November 29, 2007
Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary interventionAmit Kumar, Christopher P Cannon
Reviews in Cardiovascular Medicine|October 28, 2008
Acute coronary syndrome. Cardiovascular events after clopidogrel discontinuationChristopher P Cannon, Subroto Acharjee
Critical Pathways in Cardiology|August 31, 2010
Office-based global cardiometabolic risk assessment: a simple tool incorporating nontraditional markersSubroto Acharjee, Christopher P Cannon
Critical Pathways in Cardiology|December 2, 2010
Duration of dual antiplatelet therapy following percutaneous coronary intervention with drug-eluting stents: a review of recent evidenceSubroto Acharjee, Christopher P Cannon
Arteriosclerosis, Thrombosis, and Vascular Biology|October 22, 2010
Could direct inhibition of inflammation be the "next big thing" in treating atherosclerosis?Pradeep Natarajan, Christopher P Cannon
Nature Reviews. Cardiology|December 21, 2011
Acute coronary syndromes in 2011: Walking the tightrope between efficacy and bleedingPayal Kohli, Christopher P Cannon
Clinical Cardiology|November 30, 2012
The importance of matching language to type of evidence: avoiding the pitfalls of reporting outcomes dataPayal Kohli, Christopher P Cannon
Heart Failure Clinics|April 25, 2008
The role of statins in the prevention of heart failure after acute coronary syndromeAmit Kumar, Christopher P Cannon
Clinical Cardiology|June 29, 2012
Aspirin resistance: current status and role of tailored therapyJonathan Grinstein, Christopher P Cannon
Pageof 86